Edition:
United Kingdom

People: Cytokinetics Inc (CYTK.OQ)

CYTK.OQ on NASDAQ Stock Exchange Global Select Market

11.58USD
16 Jul 2019
Change (% chg)

-- (--)
Prev Close
$11.58
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
172,335
52-wk High
$11.85
52-wk Low
$5.76

Henderson, John 

Dr. John T. Henderson, M.B., Ch.B., is Independent Director of the Company. Dr. Henderson has served as a consultant to the pharmaceutical industry as president of Futurepharm LLC. Until his retirement in December 2000, Dr. Henderson was with Pfizer Inc. for over 25 years, most recently as a Vice President in the Pfizer Pharmaceuticals Group. Dr. Henderson previously held Vice Presidential level positions with Pfizer in Research and Development in Europe and later in Japan. He was also Vice President, Medical for Pfizer’s Europe, U.S. and International Pharmaceuticals groups. Dr. Henderson has served on the Board of Directors of Myriad Genetics, Inc., a healthcare diagnostics company, since 2004, and has served as the Chairman of Myriad’s Board of Directors since April 2005. He served on the Board of Directors of Myrexis, Inc. (formerly Myriad Pharmaceuticals, Inc.) from June 2009 until January 2013. Dr. Henderson earned his bachelor’s of science and medical degrees from the University of Edinburgh and is a Fellow of the Royal College of Physicians (Ed.) and the Faculty of Pharmaceutical Medicine.

Basic Compensation

Total Annual Compensation, USD 22,500
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 259,781
Fiscal Year Total, USD 282,281

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leonard Patrick Gage

291,926

Robert Blum

2,867,840

Ching Jaw

1,099,890

Fady Malik

1,219,940

David Cragg

388,209

Robert Wong

--
As Of  31 Dec 2017